Nader Pourhassan was CEO of CytoDyn, a Vancouver, Wash., biotech firm trading at 45 cents a share. He described a company charging toward government approval for its proprietary compound—and evoked ...
But as WW reported this month, there was evidence the fee hikes would backfire: An informal poll by a Bend-based shroom ...
Voted Best Realtor in Portland by Readers of the Willamette Week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results